In an article published on April 23, 2017, Gene Quinn wrote about President Trump’s workforce reduction plan and his proposal for what it should mean for the United States Patent and Trademark Office. I agree with many of those proposals for reducing the size of the USPTO in accordance with the mandate set forth [...]
The WHO last week announced plans to explore options for prequalifying insulin a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drug. The WHO is considering whether to extend the prequalification process to manufacturers creating me too versions of insulin more commonly known as biosimilars. [...]
A Supreme Court bench consisting of Justices Ranjan Gogoi and Navin Sinha refused to admit the IRRO appeal. Asking their counsel (Mr SC aggarwal) as to how their special leave petition (SLP) to appeal is even maintainable. Given that the original suit filed before the Delhi high court had been withdrawn by the publisher [...]
On Thursday, April 27th, legal data analytics firm Lex Machina released a Hatch-Waxman/ANDA litigation report detailing trends and key findings from pharmaceutical cases filed in U.S. district courts between January 1st, 2009, and March 31st, 2017. More than eight years worth of data shows that patent infringement case filings in response to abbreviated new drug applications (ANDAs) filed [...]
RecogniCorp owns the ’303 patent, which provides a method and apparatus for building a composite facial image using constituent parts. Prior to the ’303 patent, composite facial images were typically stored in file formats such as “bitmap,” “gif,” or “jpeg.” These formats required significant memory and compressing the images often resulted in decreased quality. [...]
Recent report states, specialist professional service consulting house Beaton research +consulting reveals results of survey. The report is going to make uncomfortable reading for executives and practitioners. Side by side it will bring comfort to partners and practitioners at privately held firms, many of whom believes that their independence present an opportunity to differentiate [...]
